We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current CRTX market cap is 70.47M. The company's latest EPS is USD -1.4296 and P/E is -1.36.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -7.62M | -6.32M | -12.96M | -5.58M | -6.16M |
Net Income | -7.92M | -5.53M | -12.25M | -4.89M | -5.35M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -12.12M | -39.17M | -78.89M | -90.32M | -52.02M |
Net Income | -12.48M | -36.98M | -76.85M | -89.95M | -51.66M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 109.78M | 103.91M | 93.32M | 88.84M | 85.39M |
Total Liabilities | 5.25M | 3.32M | 3.12M | 1.95M | 2.25M |
Total Equity | 104.53M | 100.59M | 90.2M | 86.88M | 83.13M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 72.88M | 124.37M | 189.47M | 133.23M | 103.91M |
Total Liabilities | 1.46M | 8.89M | 17.2M | 14.64M | 3.32M |
Total Equity | -32.63M | 115.48M | 172.26M | 118.59M | 100.59M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -38.2M | -44.04M | -3.57M | -7.4M | -12.21M |
Investing | -664k | 18M | 5.54M | -14.78M | -11.15M |
Financing | 725k | 707k | 50k | 76k | 86k |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -11.7M | -33.28M | -50.82M | -62.93M | -44.04M |
Investing | -46.75M | -17.75M | -52.43M | 58.95M | 18M |
Financing | 75.93M | 77.37M | 118.88M | 6.81M | 707k |
Market Cap | 70.47M |
Price to Earnings Ratio | -1.36 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 1.58 |
Price to Book Ratio | 0.7 |
Dividend Yield | - |
Shares Outstanding | 36.14M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.08 (4.02%) |
Company Name | Cortexyme Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://quincetx.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions